The global newborn screening market size was valued at USD 838 million in 2021, at a CAGR of 7.9% during the forecast period 2022 to 2028. Newborn screening is a public health programme in which new born newborns are examined and diagnosed with uncommon but dangerous medical disorders (genetic, hormonal, or metabolic abnormalities) that can disrupt the new born normal growth but are curable. Newborn screening involves a variety of tests performed within the first few hours or days of an infant's life, including a hearing test, urine test, dry blood test, and others. These tests have the ability to avert a variety of health issues as well as death. Newborn screening has progressed from a basic blood and urine test to a more thorough and complicated system capable of identifying more than 50 diseases.

View detailed report description here  https://precisionbusinessinsights.com/market-reports/newborn-screening-market/                 

The expansion of the newborn screening market is fueled by a variety of reasons, including an increasing neonatal population base and an increase in the number of incidences of congenital disorders in infants. Organizations such as the WHO, CDC, Healthy Newborn Network, and others are working to educate parents about various problems and diagnostic processes in attempt to minimize the number of deaths. North American agencies have likewise mandated that all infants delivered in private hospitals be screened. Furthermore, rising healthcare awareness, the advantages of newborn screening programmes, technical improvements in screening, and increased government funding and support are all contributing to the worldwide expansion of the newborn screening market. The production of hybrid instruments is also one of the most interesting and significant breakthroughs in this industry. To develop a presence in the industry, producers are focused on high sensitivity, resolution, throughput, and cost-effectiveness. As a result, many businesses have been impacted by new technology and have adopted a variety of innovative clinical testing platforms.

The global newborn screening market segmentation:
 1) By Technology: Electrophoresis, Immunoassays & Enzymatic assays, DNA-based Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Tandem Mass Spectrometry (TMS). 
 2) By Product Type: Newborn Hearing Screening Instruments, Newborn Disorder Screening Instruments, Hearing Screening Accessories, Hearing Screening Devices, Pulse Oximeters, Reagents and Assay Kits.
 3) By Test Type: Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) TEST. 
 4) By Distribution Channel: Hospitals, Ambulatory Surgical Centers, Nursing Homes.

North America now dominates the market for newborn screening and is projected to remain so for a few more years. This is largely due to the rising occurrence of congenital diseases and the implementation of mandatory testing in all 50 states. The United States has the greatest market share in the North American area. This is mostly due to the rising prevalence of diseases in neonates and the increased need for improved systems. Every baby in the United States is examined after delivery, and this screening is done by analyzing diagnostic markers in blood spots collected on filter paper on the second day of life. Although newborn screening programmes are handled on a state-by-state basis in the United States, there has been a lack of consistency among testing panels in many states.

Request sample report  https://precisionbusinessinsights.com/request-sample?product_id=23657                                                    
 
 The major key players working in the newborn screening market, which include Bio-Rad Laboratories, Inc. Thermo Fisher Scientific Inc. GE Healthcare PerkinElmer Inc. ZenTech S.A. Sema4 Trivitron Healthcare MP Biomedicals LLC Agilent Technologies Medtronic Natus Medical Incorporated WATERS FUJIFILM Holdings Corporation, ZenTech S.A Trivitron Healthcare Ab Sciex LLC (subsidiary of Danaher Corporation)

About Precision Business Insights:  
 We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

 

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553 

Email: [email protected]
 Kemp House, 152 – 160 City Road, London EC1V 2NX
 Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747